The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 23, 2019

Filed:

Dec. 08, 2015
Applicant:

Guangzhou Cas Lamvac Biotech Co., Ltd., Guangzhou, CN;

Inventors:

Hongxing Wang, Guangzhou, CN;

Yinzhou Fan, Guangzhou, CN;

Xueqing Chen, Guangzhou, CN;

Xiaoping Chen, Guangzhou, CN;

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/14 (2006.01); A61K 31/47 (2006.01); A61K 47/10 (2017.01); A61K 47/32 (2006.01); A61K 47/34 (2017.01);
U.S. Cl.
CPC ...
A61K 9/146 (2013.01); A61K 31/47 (2013.01); A61K 47/10 (2013.01); A61K 47/32 (2013.01); A61K 47/34 (2013.01); Y02A 50/411 (2018.01);
Abstract

The present invention relates to a hot melt extrusion composition, a process for preparing a hot melt extruded product using the hot melt extrusion composition, a solid dispersion of decoquinate, and pharmaceutical uses of the composition and the solid dispersion of decoquinate. The hot melt extrusion composition comprises 5 to 30% of decoquinate, 60 to 90% of a polymeric carrier and 0 to 10% of a surfactant. The hot melt extrusion composition can be melted into a liquid at a temperature below the melting point of decoquinate to achieve complete mixing, effectively avoiding the possible thermal decomposition of decoquinate and other components of the composition during the hot-melt process, thus retaining their original structures and pharmacodynamic activity. In the solid dispersion of decoquinate according to the present invention, the active pharmaceutical ingredient and the formulation excipients are melted into amorphous material with homogeneity, possessing improved solubility and drug releasing rate as well as enhanced oral bioavailability and efficacy.


Find Patent Forward Citations

Loading…